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Implementing a simplified targeted feedback method to reduce fluoroquinolone prescriptions in
emergency departments

Health & Services

Minh Le, PharmD, Alyssa Christensen, PharmD, BCIDP, Brent Footer, PharmD, BCPS

Background

Intervention

• The CDC has proclaimed antibiotic resistance to be
one of the biggest public health challenges of our
time.
• 60% of antimicrobials are prescribed in the outpatient
setting, and up to 30% are inappropriate.1
• Fluoroquinolones (FQ) are the third most commonly
prescribed outpatient antibiotic class in the US.2
• In 2016, the FDA released a safety communication
emphasizing the judicial use of FQs.
• The Joint Commission has recently extended their
antimicrobial stewardship requirements to the
ambulatory healthcare setting.
• Provider audit-and-feedback and education have been
shown to be among the most effective interventions.
• Auditing requires significant healthcare resources and
must be continuous to have durable efficacy.
• Best practices and optimized strategies have not yet
been determined.

Extract antimicrobial
prescription data from EHR

Distribute de-identified
aggregate data, peer
comparison, and education
materials

Preliminary Results

Objectives

Total Prescriptions by Month

Primary Objective
• Decrease total number of FQ prescriptions

Total Antibiotics

Study design
• Ongoing multicenter, pre-post study intervention
across eight emergency departments of a large
healthcare system

Intervention

Fluoroquinolones

Methodology

Intervention Material
• Data: total and monthly number of all encounters,
encounters in which any antibiotic was prescribed,
encounters in which a FQ was prescribed, FQ rate per
100 antibiotic encounters
• Education materials distributed to providers:
updated guideline recommendations and
relevant clinical pearls
Statistics
• Paired T-test
• McNemar Test

Oct

39 (21.8%)
102 (60.7%)

Preliminary Discussion

• There was a total decrease in both FQ and all antibiotic
prescriptions in the post-intervention period.
• The numbers of total encounters and FQ encounters
were significantly reduced after implementation (pvalue <0.001).
• The Pearson correlation coefficient between FQ and all
antibiotics was 0.25 (low, insignificant correlation, pvalue=0.7516), indicating no observed trends between
antibiotics and FQs.
• Using a McNemar test to account for relatively low FQ
prescription volumes, wherein monthly FQs were
counted in binary units (0 or > 1 FQ prescription) for
each provider, a statistically significant reduction in FQ
rates was detected (p-value=0.0084).
• More data points are needed to perform a paired Ttest on FQ rates, which would provide statistical
analysis on individual prescriber trends.
• There was a decreasing trend in FQ prescriptions each
month prior to implementation which cannot be
explained with the current sample size.
• There was a decrease in total FQ rate for individual
study sites, however more data is needed to perform
statistical analysis.

Nov

Dec

• Targeted provider feedback led to an overall
decrease in FQ prescriptions.
• The preliminary results are encouraging, but more
data is needed to detect the true impact of the
intervention and analyze trends.
• Future steps to improve the antimicrobial
stewardship intervention are to include provider
feedback with trends and statistics, specific diseases
where FQs are not recommended (ie. UTI) and
provide more tools to guide decision making (ie. data
regarding utility of urine analysis in specific
populations).
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Disclosure

2.0
0.0

140 (78.2%)
66 (39.3%)

Preliminary Conclusions

Population:
• All Providence emergency department prescribers in
the Oregon region
Intervention Period
• Intervention created in accordance with Joint
Commission standards
• Preliminary data includes pre-intervention period
between October – December 2019,
implementation period in January, and postintervention data between February-March 2020

Pre
Post

Synthesize FQ prescriptions
and trends by site and
provider

Record monthly trend and
statistics

• To evaluate the change in FQ prescribing within
emergency departments before and after aggregate
data, peer-comparison, and education material are
distributed to individual prescribers.
• Preliminary data will evaluate the initial impact of
the intervention.

Secondary Objectives
• Decrease FQ prescribing by individual study site and
provider

Paired T-test
Total Encounters by
Provider
310
(289,331) <.0001
Total Encounters by
FQ prescriptions
2.0
(1.6,2.3)
<.0001
Rates
(FQ/Total Encounters)
0.12
(-0.05,0.29) 0.1778
McNemar Test
(p-value=0.0084)
Total FQ > 0
Total FQ = 0

Intervention

Purpose

Labs on
admission:

Differences
95% CI
(Pre-Post) Mean Diff. p-values

Site 1

Site 2

Site 3

Site 4

Pre Intervention

Site 5

Site 6

Post Intervention

Site 7

Site 8

•
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